EUVIMEDEUVIMED entdecken
Crossref

Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone

M Katano, F Nagumo, E Kubota, H Yamamoto, T Matsuo, T Hisatsugu, J Tadano

Biotherapy · 1993

DOI: 10.1007/bf01877383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotherapy, 1993. Verfasst von M Katano und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Saga Medical School, Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mixtures of tumour infiltrating lymphocytes (TIL) and tumour cells collected from malignant ascites of a patient with pancreatic cancer were cultured using a microplate without recombinant interleukin 2(rIL2). TIL rapidly proliferated from 21-51 days after the initiation of culture in 20 out of 30 wells tested. Cytotoxicity was examined in 5 out of the 20 TIL-growing wells. One CD8+ TIL (well-1) displayed autologous tumour-specific cytotoxicity. Repeated stimulation with autologous tumour cells, in the absence of rIL2, was required for further propagation in long-term (60 days) culture of TIL. Four clones were established from well-1 by limiting dilution without rIL2. Surface phenotypes of the 4 clones were the same as those of well-1, i.e., CD8+, CD16-, CD25+, HLA-DR+. And autologous tumour cells were required for continuous proliferation of these CD8+ T-cell clones. Both well-1 and the 4 clones displayed similar degrees of cytotoxicity restricted to autologous tumour cells. These results indicate that TIL from malignant ascites may contain precursor cytotoxic T-lymphocytes (CTL) sensitized in vivo to autologous tumour cells, and that TIL are able to grow for several weeks or more with substantial increases in cell numbers in the absence of rIL2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgedAntigens, SurfaceAscitic FluidCD8 AntigensClone CellsCytokinesCytotoxicity, ImmunologicHumansInterleukin-2KineticsLymphocyte ActivationLymphocytes, Tumor-InfiltratingMalePancreatic NeoplasmsPhenotypeRecombinant ProteinsT-Lymphocytes, CytotoxicTumor Cells, Cultured

Substanzen

Antigens, SurfaceCD8 AntigensCytokinesInterleukin-2Recombinant Proteins

Autor:innen und Institutionen

  • Department of Surgery, Saga Medical School, Japan.

Zitieren

APA

Katano, M., Nagumo, F., Kubota, E., Yamamoto, H., Matsuo, T., Hisatsugu, T., & Tadano, J. (1993). Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone. Biotherapy. https://doi.org/10.1007/bf01877383

Vancouver

Katano M, Nagumo F, Kubota E, Yamamoto H, Matsuo T, Hisatsugu T, et al. Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone. Biotherapy. 1993. doi:10.1007/bf01877383

BibTeX
@article{Katano1993,
  author = {Katano, M and Nagumo, F and Kubota, E and Yamamoto, H and Matsuo, T and Hisatsugu, T and Tadano, J},
  title = {Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): Activation by autologous tumour cell alone},
  journal = {Biotherapy},
  year = {1993},
  doi = {10.1007/bf01877383}
}
Kostenlos starten →